Terumo Corporation, a global leader in medical technology, has signed a definitive agreement to acquire all assets of Health Outcomes Sciences Inc. HOS specializes in predictive analytics and clinical decision support that enable healthcare organizations to deliver personalized, predictive insights at the point of care.
“The acquisition of Health Outcomes Sciences and the ePRISM platform expands Terumo’s presence in the digital healthcare arena and represents a compelling growth opportunity for our company. It further allows Terumo to deliver innovative digital solutions, providing healthcare systems with critical data needed to lower the cost of healthcare delivery while substantially improving patient outcomes,” said Toshi Osada, president of Terumo’s cardiac and vascular company.
“When combined with Terumo’s 100-year history and commitment to transforming global healthcare, our ePRISM technology will enable healthcare providers to deliver uniquely focused patient care; improving patient satisfaction, decreasing variability, optimizing outcomes and minimizing costs. This acquisition provides Terumo with a digital solutions platform that can be scaled globally across multiple healthcare segments,” said John Spertus, founder of Health Outcomes Sciences.
The ePRISM platform will be integrated into Terumo Business Edge, a business unit of Terumo Medical Corporation that provides healthcare systems with solutions designed to reduce care variation, improve quality metrics, minimize cost and maximize revenue.